The Runt Domain Transcription Factor, PEBP2/CBF, and its Involvement in Human Leukemia
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
AML1 is the mammalian homolog of the Drosophila segmentation gene, runt , and was originally identified at the beakpoint of the chromosome translocation, t(8;21), associated with acute myeloid leukemia. Subsequently, AML1 was found to be a frequent target of chromosome translocations associated with several other types of human leukemia including that associated with t(12;21) lymphoblastic leukemia. The product of AML1 is the α subunit of transcription factor PEBP2/CBF. The DNA binding domain of AML1, termed the Runt domain, also serves as the additional function of interacting with its partner protein, the β subunit. The gene that encodes the β subunit is also the target of inversion of chromosome 16 [inv(16)], another chromosome anomaly associated with acute myeloid leukemia. This surprising observation strongly suggests that the two subunits indeed function together as a heterodimer and play an important role in hematopoiesis. Therefore, elucidation of the structure and function of the Runt domain factor, PEBP2/CBF, has become very important for our understanding of the pathogenesis of many types of human leukemia. The involvement of AML1 and the β subunit gene in various types of chromosome translocations has been reviewed recently (Nucifora and Rowley, 1995; Liu et al, 1995). Here we shall focus our discussion on reviewing the structure and the function of PEBP2/CBF and how these two subunits are structurally altered when they are activated as oncogenes by chromosome translocations. This subject has also been reviewed recently by several other investigators (Speck and Stacy, 1995; Hiebert et al, 1996 a; Ito, 1996). These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., & Downing, J. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80986-1 · Cited by 1,856
Wang, Q., Stacy, T., Binder, M., Marin-Padilla, M., Sharpe, A. H., & Speck, N. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3444 · Cited by 1,178
Miyoshi, H., Shimizu, K., Kozu, T., Maseki, N., Kaneko, Y., & Ohki, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10431 · Cited by 872
Fusion Between Transcription Factor CBFβ/PEBP2β and a Myosin Heavy Chain in Acute Myeloid Leukemia
Liu, P., Tarlé, S. A., Hajra, A., Claxton, D. F., Marlton, P., Freedman, M., Siciliano, M. J., & Collins, F. S. (1993) · Science · doi:10.1126/science.8351518 · Cited by 732
Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia.
Golub, T. R., Barker, G. F., Bohlander, S. K., Hiebert, S. W., Ward, D. C., Bray-Ward, P., Morgan, E., Raimondi, S. C., Rowley, J. D., & Gilliland, D. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4917 · Cited by 704
Erickson, P., Gao, J., Chang, K., Look, T., Whisenant, E., Raimondi, S., Lasher, R., Trujillo, J., Rowley, J., & Drabkin, H. (1992) · Blood · doi:10.1182/blood.v80.7.1825.1825 · Cited by 631
Ogawa, E., Maruyama, M., Kagoshima, H., Inuzuka, M., Lu, J., Satake, M., Shigesada, K., & Ito, Y. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6859 · Cited by 608
Self-citationThe t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion
Romana, S., Mauchauffe, M., Le Coniat, M., Chumakov, I., Le Paslier, D., Berger, R., & Bernard, O. (1995) · Blood · doi:10.1182/blood.v85.12.3662.bloodjournal85123662 · Cited by 530
Miyoshi, H., Kozu, T., Shimizu, K., Enomoto, K., Maseki, N., Kaneko, Y., Kamada, N., & Ohki, M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05933.x · Cited by 498
Ogawa, E., Inuzuka, M., Maruyama, M., Satake, M., Naito-Fujimoto, M., Ito, Y., & Shigesada, K. (1993) · Virology · doi:10.1006/viro.1993.1262 · Cited by 493
Self-citation
Cited by
TGF-β signaling by Smad proteins
Miyazono, K. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(99)00025-8 · Cited by 626
A WW domain-containing Yes-associated protein (YAP) is a novel transcriptional co-activator
Yagi, R., Chen, L.-F., Shigesada, K., Murakami, Y., & Ito, Y. (1999) · The EMBO Journal · doi:10.1093/emboj/18.9.2551 · Cited by 558
Self-citationTranscriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors
Levanon, D., Goldstein, R. E., Bernstein, Y., Tang, H., Goldenberg, D., Stifani, S., Paroush, Z., & Groner, Y. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11590 · Cited by 468
CBFA1: A molecular switch in osteoblast biology
Ducy, P. (2000) · Developmental Dynamics · doi:10.1002/1097-0177(2000)9999:9999<::aid-dvdy1074>3.0.co;2-c · Cited by 446
Levanon, D. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf370 · Cited by 437
Metadata
- Authors
- Ito, Y., & Bae, S.-C.
- Venue
- Oncogenes as Transcriptional Regulators
- Publisher
- Birkhäuser Basel
- Published
- 1997
- Pages
- 107-132
- OpenAlex
- W303958676
- Cited by
- 41
- References
- 31
- FWCI
- 19.41
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Runt Domain Transcription Factor, PEBP2/CBF, and its Involvement in Human Leukemia. https://app.cochat.ai/papers/10.1007/978-3-0348-8934-6_4
- The paper
- Ito, Y., & Bae, S.-C. (1997). The Runt Domain Transcription Factor, PEBP2/CBF, and its Involvement in Human Leukemia. Oncogenes as Transcriptional Regulators. https://doi.org/10.1007/978-3-0348-8934-6_4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.